Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine antagonists as potential therapeutic agents.

M Williams1, M F Jarvis

  • 1Research Department, CIBA-GEIGY Corporation, Summit, NJ 07901.

Pharmacology, Biochemistry, and Behavior
|February 1, 1988
PubMed
Summary

Caffeine and related xanthines act as adenosine antagonists, offering therapeutic benefits. Novel non-xanthine compounds show promise for selective adenosine receptor targeting, potentially leading to new neuromodulatory therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A selective α2 B adrenoceptor agonist (A-1262543) and duloxetine modulate nociceptive neurones in the medial prefrontal cortex, but not in the spinal cord of neuropathic rats.

European journal of pain (London, England)·2014
Same author

The Concise Guide to PHARMACOLOGY 2013/14: overview.

British journal of pharmacology·2014
Same author

Spinal microglial activation in rat models of neuropathic and osteoarthritic pain: an autoradiographic study using [3H]PK11195.

European journal of pain (London, England)·2012
Same author

Elevated temperatures alter TRPV1 agonist-evoked excitability of dorsal root ganglion neurons.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2008
Same author

Nucleotides and their receptors in the nervous system. 1-2 August 1998, Leipzig, Germany.

IDrugs : the investigational drugs journal·2008
Same author

P2X7-related modulation of pathological nociception in rats.

Neuroscience·2007

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Caffeine, a widely consumed methylxanthine, exhibits therapeutic effects by antagonizing adenosine.
  • Xanthines inhibit phosphodiesterase, mobilize calcium, and affect neurotransmitter uptake.
  • Adenosine receptor selectivity has been a challenge for developing xanthine-based therapeutics.

Purpose of the Study:

  • To explore novel non-xanthine adenosine antagonists.
  • To identify compounds with improved selectivity for adenosine receptors.
  • To investigate new therapeutic agents targeting neuromodulator function.

Main Methods:

  • Review of existing literature on xanthine and non-xanthine adenosine antagonists.
  • Identification and characterization of novel non-xanthine compounds like CGS 15943 A and HTQZ.

Related Experiment Videos

  • Assessment of adenosine receptor antagonist activity and selectivity.

    • Main Results:

    • Several non-xanthine compounds, including pyrazolopyrimidines, pyrazoloquinolines, and pyrazolopyridines, exhibit adenosine antagonist activity.
    • CGS 15943 A identified as the first potent, A2-selective non-xanthine adenosine antagonist (IC50 = 3 nM).
    • HTQZ demonstrates 25-fold selectivity for the A2 receptor.

    Conclusions:

    • Novel non-xanthine adenosine antagonists offer improved receptor selectivity.
    • These compounds represent a new class of therapeutic agents.
    • Potential for developing treatments that modulate neuromodulator function.